1 |
Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF, Steegers-Theunissen RP and Eskes TK. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 60: 820-825, 1993
|
2 |
Goddijn-Wessel TAW, Wouters MGAJ, v.d. Molen EF, Spuijbroek MDEH, Steegers-Theunissen RPM, Blom HJ, Boers GHJ Eskes TKAB. Hyperhomocysteinemia: A risk factor for placental abruption or infarction. Eur J Obstet Gynecol 66: 23-29, 1996
DOI
ScienceOn
|
3 |
Kang SS, Wong PWK, Cook HY, Norusis M, Messer JV. Protein-bound homocyst (e) ine. J Clin Invest 77: 1482-1486, 1986
DOI
|
4 |
Perry DJ. Hyperhomocysteinaemia. Baillieres Clin Heamatol 12: 451-477, 1999
|
5 |
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard C, Matthews R. Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet lO: 111-113, 1995
DOI
ScienceOn
|
6 |
Picciano MF. Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes? Am J Clin Nutr 71: 857-858, 2000
|
7 |
Bondevik GT, Schneede J, Refsum H, Lie RT, Ulstein M, Kvale G. Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr 55: 856-864, 2001
DOI
|
8 |
Khong TY, Hague WM. The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol 106(3): 273-278, 1999
DOI
|
9 |
Gebhardt GS, Scholtz CL, Hillermann R, Odendaal HJ. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol 97(2): 174-177, 2001
DOI
ScienceOn
|
10 |
Schuster K, Bailey LB, Mahan CS. Vitamin status of lowincome adolescent and adult pregnant women and the condition of their infants at birth. Am J Clin Nutr 34(9): 1731-1735, 1981
|
11 |
Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin. Chem 46(8 Pt 1): 1065-1071, 2000
|
12 |
Leena M, Riyazi N, de Vries JIP, Jakobs C, van Geijn HP, Dekker GA. Effects of folic acid and vitamin <TEX>$B_6$</TEX> supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 179: 135-139, 1998
DOI
ScienceOn
|
13 |
Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93: 15227-15232, 1995
DOI
ScienceOn
|
14 |
Jacques PF, Kambach R, Bagley P, Russo GT, Rogers G, Wilson PWF, Roseberg IH, Selhub J. The relationship between riboflavin and plasma total homocysteine in the Framingham offspring cohort is influenced by folate status and the C677T transition in the methylentetrahydrofolate reductase gene. J Nutr 132: 283-288, 2002
|
15 |
Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 71: 1295S-1303S, 2000
|
16 |
Bruinse HW, van den Berg H. Changes of some vitamin levels during and after normal pregnancy. Eur J Obstet Gynecol 61: 31-37, 1995
DOI
ScienceOn
|
17 |
Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 180: 660-664, 1999
DOI
ScienceOn
|
18 |
Ahn HS, Lee GJ, Chung HW. Maternal vitamin B6 intake and vitamin level in maternal, umbilical cord plasma and placenta. Korean J Nutr 35: 322-331, 2002
|
19 |
Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen ALB, Ueland PM. Plasma total homocysteine, pregnancy complications and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 71 : 962-968, 2000
|
20 |
Bates CJ, Fuller NJ. The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat. Br J Nutr 55: 455-464, 1986
DOI
ScienceOn
|
21 |
Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP. A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70: 310-315, 2000
DOI
ScienceOn
|
22 |
McNulty H, McKinley MC, Wilson B, McPartlin J, Strain JJ, Weir DG, Scott JM. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 76: 436-441, 2002
|
23 |
Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 422: 43-52, 1987
DOI
ScienceOn
|
24 |
Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy-review of our present understanding and therapeutic implications. Eur J Obstet Gynecol 93: 157-165, 2000
DOI
ScienceOn
|
25 |
Ahn HS, Kim JS, Lee GJ, Kim YT. Serum folate levels of maternal-umbilical cord blood and pregnancy outcomes. Korean J Nutr 33(8): 840-847, 2000
|
26 |
Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157: 451-456, 2001
DOI
ScienceOn
|
27 |
Ahn HS, Lee GJ, Kim YT. Relationship between vitamin status of maternal-umbilical cord plasma and pregnancy outcomes. Korean J Nutr 33(3): 263-270, 2000
|
28 |
van den Berg M, Franken DG, Boers GHJ, Blom HJ, Jakobs C, Stehouwer CDA, Rauwerda JA. Combined vitamin plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg 20: 933-940, 1994
DOI
ScienceOn
|
29 |
Alfirevic Z, Mousa HA, Martlew V, Briscoe L, Perez-Casal M, Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 97 (5 Pt 1): 753-9, 2001
DOI
ScienceOn
|
30 |
Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends in Pharmacol Sci 22: 195-201, 2001
DOI
ScienceOn
|
31 |
Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet 351: 35, 1998
DOI
ScienceOn
|
32 |
Locksmith GJ, Duff P. Preventing neural tube defects: the importance of periconceptional folic acid supplements. Obstet Gynecol 91: 1027-1034, 1998
DOI
ScienceOn
|
33 |
Burke G, Robinson K, Refsum H, Stuart B, Drumm J, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 326: 69-70, 1992
|
34 |
van der Put NMJ, Blom HJ. Neural tube defects and a disturbed folate dependent homocyssteine metabolism. Eur J Obstet Gunecol Reprod Biol 92 : 57-61, 2000
DOI
ScienceOn
|
35 |
Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK. Genetic Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; A report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107: 162-168. 2002
DOI
ScienceOn
|
36 |
Schuster K, Bailey LB, Mahan CS. Effect of maternal pyridoxine X HCl supplementation on the vitamin B-6 status of mother and infant and on pregnancy outcome. J Nutr 114(5): 977-988, 1984
|
37 |
Botticher B, Botticher D. A new HPLC-method for the simultaneous determination of , and vitamers in serum and whole blood. Int J Vitam Nutr Res 57: 273-298, 1987
|
38 |
Cikot RJLM, Steegers-Theunissen RPM, Thomas CMG, de Boo TM, Merkus HMWM, Steegers EAP. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 85: 49-58, 2001
DOI
ScienceOn
|
39 |
Mill JL, McPartlin JM, Kirke PN. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345: 149-151, 1995
DOI
ScienceOn
|